| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-7 Days |
| Number of Subjects | 28 |
| Gender | Both Genders |
| Age Range | 1-6 |
| Body Types | Average |
In children with upper respiratory tract infections associated with transient hypogammaglobulinemia of infancy, supplementation of 1.5mL (10 drops) of EPs-7630 thrice daily for a week was able to significantly benefit nasal congestion (71.4% of treatment having no congestion relative to 21.5% of placebo) and appetite. Fever, cough, well being, and myalgia were not affected.
